Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab von Frerichs, Kristine A, Broekmans, Marloes E C, Marin Soto, Jhon A, van Kessel, Berris, Heymans, Martijn W, Holthof, Lisa C, Verkleij, Christie P M, Boominathan, Rengasamy, Vaidya, Bhavesh, Sendecki, Jocelyn, Axel, Amy, Gaudet, Francois, Pillarisetti, Kodandaram, Zweegman, Sonja, Adams, 3rd, Homer C, Mutis, Tuna, van de Donk, Niels W C J

Volltext

Anti-human Vascular Endothelial Growth Factor (VEGF) Antibody Selection for Immunohistochemical Staining of Proliferating Blood Vessels von van der Loos, Chris M, Meijer-Jorna, Lorine B, Broekmans, Marloes E.C, Ploegmakers, Hanneke P.H.M, Teeling, Peter, de Boer, Onno J, van der Wal, Allard C

Volltext

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification von Valentijn, Linda J, Koster, Jan, Haneveld, Franciska, Aissa, Rachida Ait, van Sluis, Peter, Broekmans, Marloes E. C, Molenaar, Jan J, van Nes, Johan, Versteeg, Rogier

Volltext

Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab von Krejcik, Jakub, Frerichs, Kris A, Nijhof, Inger S, van Kessel, Berris, van Velzen, Jeroen F, Bloem, Andries C, Broekmans, Marloes E C, Zweegman, Sonja, van Meerloo, Johan, Musters, René J P, Poddighe, Pino J, Groen, Richard W J, Chiu, Christopher, Plesner, Torben, Lokhorst, Henk M, Sasser, A Kate, Mutis, Tuna, van de Donk, Niels W C J

Volltext

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma von Verkleij, Christie P.M., Broekmans, Marloes E.C., van Duin, Mark, Frerichs, Kristine A., Kuiper, Rowan, de Jonge, A. Vera, Kaiser, Martin, Morgan, Gareth, Axel, Amy, Boominathan, Rengasamy, Sendecki, Jocelyn, Wong, Amy, Verona, Raluca I., Sonneveld, Pieter, Zweegman, Sonja, Adams, Homer C., Mutis, Tuna, van de Donk, Niels W.C.J.

Volltext

Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies von Verkleij, Christie P M, Jhatakia, Amy, Broekmans, Marloes E C, Frerichs, Kristine A, Zweegman, Sonja, Mutis, Tuna, Bezman, Natalie A, van de Donk, Niels W C J

Volltext

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma von Verkleij, Christie P.M., Frerichs, Kristine A., Broekmans, Marloes E.C., Duetz, Carolien, O'Neill, Chloe A., Bruins, Wassilis S.C., Homan‐Weert, Paola M., Minnema, Monique C., Levin, Mark‐David, Broijl, Annemiek, Bos, Gerard M.J., Kersten, Marie José, Klein, Saskia K., Shikhagaie, Medya M., Casneuf, Tineke, Abraham, Yann, Smets, Tina, Vanhoof, Greet, Cortes‐Selva, Diana, Steenbergen, Laure, Ramos, Elena, Verona, Raluca I., Krevvata, Maria, Sonneveld, Pieter, Zweegman, Sonja, Mutis, Tuna, Donk, Niels W.C.J.

Volltext